NurExone to Collaborate with Polyrizon for Intranasal Administration of Cutting-Edge Exosome-Therapy

“ExoTherapy”, NurExone’s proprietary Exosome siRNA loaded product, is being developed to recover functionality in patients with traumatic spinal cord injuries read more